Exelixis First Quarter 2022 Financial Results. See Also: Milestones in Clinical and Pipeline Development
May 19, 2022
0
Exelixis Press Release This press release covers a large part of Exelixis accomplishments, including important details about its pipeline products, especially, cabozantinib, in addition to new results from clinical trials. We advise Prohost subscribers to read this press release, so they can get a better understanding about this firm and why we believe it a great achiever. Exelixis On May 10, Exelixis (